LaSalle St. Investment Advisors’s AbbVie ABBV Stock Holding History

LaSalle St. Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.07M	Buy	8,240 +78	+1%	+$16.8K	0.25%	72
2026 Q1	$1.78M	Sell	8,162 -46	-0.6%	-$10.2K	0.25%	68
2025 Q4	$1.88M	Buy	8,208 +491	+6%	+$112K	0.3%	54
2025 Q3	$1.79M	Buy	7,717 +231	+3%	+$47K	0.32%	52
2025 Q2	$1.39M	Sell	7,486 -441	-6%	-$82K	0.38%	53
2025 Q1	$1.66M	Sell	7,927 -51	-0.6%	-$9.91K	0.39%	42
2024 Q4	$1.42M	Buy	7,978 +2,222	+39%	+$409K	0.44%	39
2024 Q3	$1.14M	Buy	5,756 +785	+16%	+$147K	0.45%	37
2024 Q2	$853K	Buy	4,971 +819	+20%	+$136K	0.43%	42
2024 Q1	$657K	Buy	4,152 +304	+8%	+$52.4K	0.37%	43
2023 Q4	$596K	Sell	3,848 -312	-8%	-$45.5K	0.4%	39
2023 Q3	$620K	Buy	4,160 +652	+19%	+$95.7K	0.3%	44
2023 Q2	$472K	Sell	3,508 -2,324	-40%	-$341K	0.21%	60
2023 Q1	$929K	Buy	5,832 +1,618	+38%	+$247K	0.41%	41
2022 Q4	$681K	Buy	+4,214	New	+$646K	0.32%	45

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LaSalle St. Investment Advisors's ABBV Position: Q2 2026 in Review

LaSalle St. Investment Advisors increased its AbbVie (ABBV) stake by 0.96% in Q2 2026, buying an estimated $16.8K and bringing the position to 8,240 shares worth $2.07M. The position accounts for 0.25% of the portfolio, ranked #72.

LaSalle St. Investment Advisors first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

LaSalle St. Investment Advisors held 8,240 shares of AbbVie worth $2.07M as of Q2 2026.
LaSalle St. Investment Advisors bought 78 AbbVie shares in Q2 2026, an estimated $16.8K.
AbbVie made up 0.25% of LaSalle St. Investment Advisors's portfolio in Q2 2026, its #72 holding.
LaSalle St. Investment Advisors first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LaSalle St. Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.